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Antigen recognition of peptide-major histocompati-
bility complexes (pMHCs) by T cells, a key step in
initiating adaptive immune responses, is performed
by the T cell receptor (TCR) bound to CD3 hetero-
dimers. However, the biophysical basis of the trans-
mission of TCR-CD3 extracellular interaction into a
productive intracellular signaling sequence remains
incomplete. Here we used nuclear magnetic reso-
nance (NMR) spectroscopy combined with muta-
tional analysis and computational docking to derive
a structural model of the extracellular TCR-CD3 as-
sembly. In the inactivated state, CD3gε interacts
with the helix 3 and helix 4-F strand regions of the
TCR Cb subunit, whereas CD3dε interacts with the
F and C strand regions of the TCR Ca subunit in
this model, placing the CD3 subunits on opposing
sides of the TCR. This work identifies the molecular
contacts between the TCR and CD3 subunits, identi-
fying a physical basis for transmitting an activating
signal through the complex.
INTRODUCTION
The T cell receptor (TCR) performs the dual role of antigen recog-
nition and signal transduction in T cell immune responses and
plays an important role in viral infections, cancer, inflammation,
and autoimmunity (Germain and Stefanova´, 1999). The TCR is
a heterodimeric molecule with each subunit possessing a con-
stant domain (Ca or Cb) (Davis and Bjorkman, 1988; Krogsgaard
and Davis, 2005) and a variable domain (Va or Vb) that contains
the complementarity-determining regions (CDRs) for peptide-
major histocompatibility complex (pMHC) binding. The TCR
lacks intracellular signaling domains but interacts with the
CD3dε, CD3gε, and CD3zz subunits, each of which possess
intracellular immunoreceptor tyrosine-based activation motifsCell(ITAMs) for phosphorylation (Kane et al., 2000; Kuhns and Davis,
2012). The extracellular interactions of the TCR and CD3 sub-
units and the orientation of the CD3 subunits on the TCR-CD3
complex have been a subject of much dispute over the last
two decades. Previous studies have identified CD3-interacting
sites on the TCR, although this was achieved by mutagenesis
and other indirect methods (Kuhns and Davis, 2012). The FG
loop in TCR Cb and the DE loop in TCR Ca have been shown
to interact with CD3gε and CD3dε, respectively, whereas the
CC’ loop in TCR Cb has been found to interact with both
CD3gε and CD3dε (Kim et al., 2010; Kuhns and Davis, 2007).
A cavity formed between the Cb FG loop and the Ca CD and
EF loops is hypothesized to accommodate a CD3ε domain
(Ghendler et al., 1998). Conformational changes have been
implicated in the AB loop of the TCR Ca domain (Beddoe
et al., 2009) and on the CD3ε subunit (Martı´nez-Martı´n et al.,
2009), indicating potential interactions. Moreover, the crystal
structures of CD3gε (Kjer-Nielsen et al., 2004) and CD3dε (Arnett
et al., 2004) suggest other putative TCR binding sites. The Cb FG
loop has been shown to act as a lever applying force on CD3ε
after pMHC ligation in the ‘‘mechanosensor’’ model (Kim et al.,
2009). Recently, a nuclear magnetic resonance (NMR) chemical
shift perturbation (CSP) study identified the helix 3 and helix 4 re-
gions as interaction sites for both CD3 subunits (He et al., 2015).
However, CD3 subunit interaction with the TCR a subunit was
not investigated in that study. Therefore, a complete molecular
picture of the extracellular TCR-CD3 complex is still not avail-
able. Understanding these molecular interactions is necessary
to fully understand the signal transduction process during
T cell activation and may identify potential therapeutic targets.
We used NMR to identify the CD3-TCR contact sites by map-
ping NMR spectral changes within the TCR upon titration of
CD3gε or CD3dε. These data, along with functional measure-
ments in T cell hybridomas, were used as a filter for all energet-
ically reasonable, computationally docked complexes of CD3gε
andCD3dεwith the TCR to identify themost likely binding sites of
the extracellular CD3 subunits on the TCR. A single TCR-CD3
interaction fitting a two-sided model (Sun et al., 2004) was signif-
icantly more compatible with experimental measurements thanReports 14, 2833–2845, March 29, 2016 ª2016 The Authors 2833
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Figure 1. 2B4bLa-CD3gε Titration Indicating Helix 3, the Helix 4-F Strand, and the FG Loop as Interacting Regions
(A) Illustration of 2B4 TCR, CD3gε, and CD3dε components (in no specific orientation) with variable domains (Va and Vb), constant domains (Ca and Cb), and
CDRs indicated on the TCR.
(B) Overlay of 15N-TROSY spectra of perdeuterated 15N-labeled 2B4bLa:deuterated unlabeled CD3gε ratios of 1:0 (green), 1:2 (cyan), 1:5 (orange), and 1:9 (red).
(C and D) Magnified views of the chemical shift perturbations of Q138 (C) and N205 and W200 (D).
(E) Plot of peak intensities of Q138, N205, and W200 with increasing CD3gε.
See also Figure S1.all other models. Thismodel is not compatible with the one-sided
model proposed previously (He et al., 2015; Kuhns et al., 2010)
but is compatible with a TCR-CD3dε small-angle X-ray scattering
(SAXS) study (Birnbaum et al., 2014). Our data show that CD3gε
interacts with residues of the helix 3 and helix 4-F strand on the
TCR b subunit and that CD3dε interacts on the opposite side with
residues of the F and C strands on the TCR a subunit.
RESULTS
CD3 Interaction Sites on the TCR Identified by NMR
Chemical Shift Perturbation Analysis
Previous NMR and crystallographic studies of the TCR have
been confounded by its large size (extracellular components
50 kDa), asymmetry, and flexibility (Kass et al., 2014; Rudolph
et al., 2006). To overcome these problems, a 2B4 TCR construct
has been developed to improve expression (with human LC13
constant domains), solubility, and folding (Berg et al., 1989;
Newell et al., 2011), enabling individual labeling of each subunit
to separately incorporate (2H-13C-15N)- or (2H-15N)-labeled and
2H-perdeuterated forms. Selective labeling enabled separate
backbone NMR assignment of each a and b 2B4 monomer sub-
unit within the heterodimer (Figures S1A and S1D). The back-
bone resonance assignments were obtained using transverse
relaxation-optimized spectroscopy (TROSY)-based triple-reso-
nance experiments (Salzmann et al., 1998; Figure S2). Using
1H-15N TROSY, 1H-15N chemical shift changes in the TCR
were measured using perdeuterated 15N-labeled 2B4-a or
2B4-b subunits separately in the presence of its unlabeled per-
deuterated heterodimer counterpart (2B4-b or 2B4-a, respec-
tively). By titrating these two proteins with an increasing amount
of deuterated CD3 (Figures S1B, S1C, S1E, and S1F), which is
invisible to the NMR, the CSPs that identify changes in the local
atomic environment and cross-peak intensities that result from2834 Cell Reports 14, 2833–2845, March 29, 2016 ª2016 The Authordynamic changes can be localized upon titration. We signifi-
cantly reduced the spectral complexity by using specific subunit
labeling and lessened the signal relaxation effects by using per-
deuteration, leading us to identify specific residues in the TCR
Ca and Cb domains as CD3 interaction sites.
To identify TCR residues critical for the interaction with CD3
subunits, we analyzed the binding interaction of CD3gε to
2B4bLa (where bL indicates that only the b subunit is labeled)
by CSP analysis (Figure 1B). Prominent intensity changes occur
within the more flexible N-terminal region—at the edges of b
sheets (A18, F64, I78, and S86), highlighting concerted struc-
tural shifts in the TCR upon CD3gε interaction—in CDR regions
Q55 and Q56 (both CDR2) and near CDR regions A92 and
S93 (near CDR3). However, more localized changes occur at
I134, Q138 (Figures 1C and 2A), and K139 in the helix 3 region
and F199, W200, R204, and N205 (Figures 1D and 2A) in the
helix 4-F strand region of the b subunit. CSP changes were
seen for residue E133 within helix 3 and T141 contacting helix
3 (Figure 2B). No significant CSP was observed in the CC’ loop;
however, residues V160 and V169 flanking the CC’ loop did
exhibit CSP. The FG loop residues F213 and S217 showed in-
tensity changes, and T223 showed CSP upon CD3gε addition.
The FG loop had three residues that showed spectral changes,
indicating that this loop interacts weakly with CD3gε in the in-
activated state. 2B4bLa-CD3gε titration identified a contiguous
site consisting of the helix 3 and helix 4-F strand on the b sub-
unit as the CD3gε interaction site (Figure 3A). The interactions
that were observed imply weak mM-mM association based on
the concentrations needed to achieve detectible chemical shift
perturbations and intensity changes. Recently, He et al. (2015)
identified the helix 3 and helix 4 regions as interaction sites for
both CD3 subunits. Prior studies have not identified the helix 3
and helix 4-F strand as TCR b-CD3gε interaction sites (Beddoe
et al., 2009; Kuhns and Davis, 2007, 2012); however, NMR hass
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Figure 2. Plot of Scaled Chemical Shift
Difference and Intensity Changes to Identify
Interacting Residues
(A) Plot of ratio of NMR signal intensity between the
CD3gε-saturated state and CD3gε-free state (I/I0)
versus residue number of the TCR b subunit.
(B) Plot of scaled chemical shift difference be-
tween the CD3gε-free state and the CD3gε-satu-
rated state versus the residue number of the TCR b
subunit.
(C) Plot of ratio of NMR signal intensity between the
CD3gε-saturated state and CD3gε-free state (I/I0)
versus residue number of the TCR a subunit.
(D) Plot of scaled chemical shift difference be-
tween the CD3gε-free state and the CD3gε-satu-
rated state versus the residue number of the TCR a
subunit.
(E) Plot of ratio of NMR signal intensity between the
CD3dε-saturated state and CD3dε-free state (I/I0)
versus residue number of the TCR b subunit.
(F) Plot of scaled chemical shift difference between
the CD3dε-free state and the CD3dε-saturated
state versus the residue number of the TCR b
subunit.
(G) Plot of ratio of NMR signal intensity between
the CD3dε-saturated state and CD3dε-free state
(I/I0) versus residue number of the TCR a subunit.
(H) Plot of scaled chemical shift difference be-
tween the CD3dε-free state and the CD3dε-satu-
rated state versus the residue number of the TCR a
subunit. The lines in the plots indicate thresholds at
1s above/below the 25% trimmedmean deviation.
See also Figures S2–S4.greater sensitivity for detection of weak binding in comparison
with other techniques (Zuiderweg, 2002).
Corresponding analysis of 2B4aLb (only a is labeled) in the
presence of CD3gε displayed few intensity changes or CSPs
(Figures 2C and 2D). Several variable region residues showed
CSPs (V6 and E7) and intensity changes (E57, Y71, and G85)
upon CD3gε titration. These residues were present at the
edges of b strands, suggesting concerted structural changes
upon CD3gε binding. Peak intensities were reduced in the C
strand residues N146, Q149, D152, and S134, and CSP was
observed in C136 (Figure S3C). The paucity of interactions on
the 2B4 a subunit and numerous contacts of CD3gε on the
2B4 b subunit indicate a strong preference for association
with the b subunit.
Analyzing the interactions between 2B4bLa and CD3dε yielded
results similar to the 2B4aLb-CD3gε interaction (Figure 3C). CSP
was seen for Q224 in the FG loop (Figure S3F) and F120 (Fig-
ure S3G), which is present on the opposite face of the CD3gε
interaction site of the TCR (Figure 3D). Sporadic residues
belonging to Vb (R42) and Cb helix 3 (Q138) (Figure S3E) show
CSP, possibly because of non-specific interactions with the ε
subunit shared by both CD3 subunits. No residues in the
CC’-loop, previously implicated in CD3dε binding (Kuhns and
Davis, 2007), showed significant spectral changes.CellInteractions between 2B4aLb and CD3dε indicated spectral
changes in the F strand residues N180 and F184 (both showing
CSP) (Figure S3K) and K181 (intensity change). The C strand
adjacent to the F strand had residues Q149 and S150 showing
CSP. The C-terminal tail residues D198 and T199 showing in-
tensity changes (Figure S3I) and E205 showing CSP (Fig-
ure S3J) also showed spectral changes. All of these residues
are located on the site opposite the CD3gε interaction site (Fig-
ure 3D). However, M165 in the DE loop, previously shown to
interact with CD3dε (Kuhns and Davis, 2007), showed CSP
but other residues in the DE loop did not. Chemical shift
perturbation analysis with higher concentrations of per-
deuterated 15N-labeled 2B4a and unlabeled CD3dε showed
increased CSP in the Ca F and C strands (Figures S4A and
S4B), validating our results shown in Figures 2H and 3D. Our
2B4aLb-CD3dε interaction experiments determined that
CD3dε interaction regions on the a subunit of the TCR include
the F strand, C strand, and C-terminal tail.
Furthermore, we performed reciprocal chemical shift pertur-
bation experiments in which the 15N-labeled CD3 subunits
were titrated with increasing amounts of unlabeled TCR (Fig-
ure 4). Although the human CD3 subunits are unassigned, this
indicates the presence of corresponding chemical shifts and in-
tensity changes upon addition of the unlabeled CD3 subunit toReports 14, 2833–2845, March 29, 2016 ª2016 The Authors 2835
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Figure 3. Mapping NMRChemical Shift Changeswithin the TCR Indicates that CD3gε Interacts with Residues of Helix 3, the Helix 4-F Strand,
and the FG Loop on the TCR b Subunit and that CD3dε Interacts with Residues of the F Strand and C-Terminal Tail on the TCR a Subunit
(A) Ribbon and surface plot of 2B4, with chemical shift-perturbed regions (residues that show dppm above 25% trimmed mean + 1s) upon titrating with CD3gε
indicated in blue. The residues that show changes in peak intensity (residues that show I/I0 below 25% trimmedmean 1s) are indicated in red. The residues that
show both CSP and intensity changes are indicated in purple. Unassigned regions are indicated in green on the ribbon diagram. Regions showing intensity
changes include helix 3, the helix 4-F strand, and the FG loop on the b subunit. Unassigned regions are indicated in green on the ribbon diagram.
(B) Ribbon and surface plot of 2B4 on the reverse face (180 rotation).
(C) Ribbon and surface plot of 2B4 upon titrating with CD3dε.
(D) Ribbon and surface plot of 2B4 TCR on the reverse face (180 rotation). Regions showing chemical shift changes include the C-terminal tail and F strand. Part
of the C-terminal tail is missing in the 2B4 structure (Newell et al., 2011).
See also Figure S4.labeled 2B4, confirming the interaction between CD3s (CD3gε
and CD3dε) and 2B4 TCR.
In summary, we show that CD3gε induced spectral changes in
helix 3 andhelix 4-F strand residues in theTCRb subunit. The res-
idues of the Cb CC’ loop, previously reported in CD3gε and
CD3dε binding (Kuhns and Davis, 2007, 2012), failed to display
significant NMR changes upon CD3gε or CD3dε titration despite
its close proximity to the CD3gε-interacting helix 3 and helix 4-F
regions. The Cb FG loop region, shown to act as a lever on the
CD3ε subunit (Kim et al., 2009) upon antigen ligation, displayed
sparse interactions with CD3gε and CD3dε individually. This sug-
gests that the Cb FG loopmay beweakly involved in CD3 binding
in the inactivated state. Similarly, we showed that CD3dε inter-
acts at the site opposite to the CD3gε interaction site through
the F strand, C strand, and C-terminal tail of the TCR a subunit.
This contrasts with a previous study wherein Ca F and C strands
were implicated in TCR-TCR interactions (Kuhns et al., 2010),
leading toTCRclustering, aswell as recentNMRresults indicating
that both CD3gε and CD3dε associate with Cb helix 3 and helix 4
on the TCR (He et al., 2015). The only other reported site for
CD3dε interaction, the Ca DE loop (Kuhns and Davis, 2007), did
not produce significant perturbation in our NMR studies. How-
ever, our NMR results are in general agreement with the TCR-
CD3dε SAXS structural study (Birnbaum et al., 2014).2836 Cell Reports 14, 2833–2845, March 29, 2016 ª2016 The AuthorMutagenesis and Functional Studies Validate the NMR-
and CSP-Identified TCR-CD3 Interactions
Residues that display peak intensity changes or CSPmay not be
directly involved in TCR-CD3 interaction but could undergo allo-
steric, structural, or conformational change upon CD3 interac-
tion (Chen et al., 2014; Zuiderweg, 2002). We identified regions
on the TCR variable domains that show CSP and intensity
changes with CD3 addition, but these are clearly not the sites
for CD3 interactions because they are involved in pMHC interac-
tions (Rudolph et al., 2006). Based on our NMR results, we
devised site-directed mutation and functional studies in T cell
hybridoma 58/ (Letourneur and Malissen, 1989; Zhong et al.,
2010) to determine whether NMR-identified residues are impor-
tant for T cell activation. The functional assays used a mouse
TCR-CD3 system because most of the mutated residues are
conserved between human and mouse TCR constant domains
(Figure 5A). Residues that undergo intensity changes/CSP
upon addition of CD3 or are nearby were selectively mutated
to alanine (Figure 5A). Double alanine mutants were made to
decrease the effects of these residues in T cell activation without
blocking TCR expression (Kuhns and Davis, 2007). TCR genes
were cloned into a retroviral vector to express mutated mouse
2B4 TCR variants. Specific sites targeted included the Cb helix
3, Cb helix 4-F strand, Cb CC’ loop, Cb FG loop, Ca F strand,s
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Figure 4. Reciprocal Chemical Shift Perturbation Experiments Using 15N-labeled CD3 Subunits and Unlabeled 2B4 Indicate Interactions
between Them
(A) 15N-TROSY spectra of deuterated 15N-labeled CD3gε and close view of 15N-TROSY overlays of deuterated 15N-labeledCD3gε:protonated unlabeled 2B4with
CD3gε:2B4 ratios of 1:0 (green), 1:2 (cyan), and 1:2.7 (red).
(B) 15N TROSY spectra of protonated 15N-labeled CD3dε and close view of 15N-TROSY overlays of protonated 15N-labeled CD3dε:protonated unlabeled 2B4with
CD3dε:2B4 ratios of 1:0 (green), 1:1.5 (cyan), and 1:2.5 (red). Selected peaks (asterisks) showing chemical shift perturbations are indicated.
(C) MALS analysis of 100 mM CD3dε indicating the protein eluting as a monomer.and Ca C-terminal tail (Figure 5B). T cells expressing wild-type
2B4 TCR andmutated TCRs were activated by Chinese hamster
ovary (CHO) cells expressing pMHC (I-Ek/K5) (Krogsgaard et al.,
2005), and interleukin-2 (IL-2) production was quantified by
ELISA (Malecek et al., 2013; Figure S5). The area under the curve
for IL-2 production, an overall measure for cumulative response
(Hioe et al., 2010; Malecek et al., 2014), was determined and
compared with the wild-type to identify the change in IL-2
production.
The Cb helix 3 mutants E133A/I134A, N136A, N136A/K137A,
and Q138A/K139A showed decreased IL-2 production
comparedwith thewild-type (Figure 5C). E133A/I134A produced
the least amount of IL-2 (89% decrease) among the helix 3 mu-Celltants. These two residues are highly conserved across species
and showed the most CSP (E133) and intensity change (I134)
among helix 3 residues upon CD3gε titration. N136A produced
more IL-2 in comparison (25% decrease) with the other helix 3
mutants. N136 is not conserved among various species and is
replaced by both basic and acidic residues in rabbit and rat,
respectively (Figure 5A). N136A/K137A (55% decrease) and
Q138A/K139A (57% decrease) produced less than half of the
IL-2 as the wild-type. Q138 and K139 are conserved between
various species, but Q138A/K139A did not have as dramatic
an effect as E133A/I134A.
To identify whether any part of the CC’ loop is involved in CD3
interaction (Kuhns and Davis, 2007), we tested the Cb CC’ loopReports 14, 2833–2845, March 29, 2016 ª2016 The Authors 2837
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Figure 5. Mutagenesis and Functional Analysis in TCells Indicate 2B4CbHelix 3 and theCbHelix 4-F Strand as Important for TCell Activation
(A) Sequence alignment of 2B4 regions from various species, indicating conserved residues and the locations of the alanine mutations tested in T cells.
(B) 2B4 TCR (PDB ID 3QJF) with mutated regions indicated in orange (Cb helix 3), red (Cb CC’ loop), magenta (Cb helix 4-F strand), gray (Cb FG loop), and blue
(Ca C-terminal tail).
(C) Percentage change in area under the curve for IL-2 cytokine produced by hybridoma expressing wild-type 2B4 or the indicated mutant when activated by
I-Ek/K5 complexes displayed on CHO cells.
See also Figure S5.mutants G162A/K163A, K163A/E164A, and H166A/S167A even
though we could not assign H166 and S167 in the 2B4b spectra.
G162A/K163A (14% decrease) and K163A/E164A (34%
decrease) produced reasonable amounts of IL-2 compared
with the wild-type. H166A/S167A produced significantly less
IL-2 (79% decrease) compared with the wild-type, suggesting
its role in T cell activation.
The Cb helix 4-F strand mutants H201A/N202A, R204A/
N205A, and N205A/H206A produced significantly less IL-2
(77.6%, 81.0%, and 86.5% decreases, respectively; Figure 5C).
However, the other Cb helix 4-F strand mutants, N202A/P203A
and P203A/R204A, produced IL-2 amounts comparable
(32.2% and 10.3% increases, respectively) with the wild-type,
suggesting that these residues may not have a direct role in
T cell activation even though R204 showed intensity changes
upon CD3gε addition.
The Cb FG loop mutant E224A/S226A produced less IL-2
(34% decrease) compared with the wild-type. The FG loop is2838 Cell Reports 14, 2833–2845, March 29, 2016 ª2016 The Authorabout 20 residues long (Das et al., 2015; Newell et al., 2011),
and the effect of a small number of amino acid changes may
not be drastic.
The Ca F strand mutants N180A/Q181A and F184A/T185A
and the Ca C-terminal tail mutant N198A produced similar
amounts of IL-2 compared with the wild-type (4.9% increase,
3.7% increase, and 4.5% decrease, respectively), suggesting a
weaker influence on T cell activation. The other Ca tail mutant,
Y201A/P202A, produced slightly less IL-2 (24.2% decrease)
compared with the wild-type.
To summarize, we identified E133, I134, K137, Q138, and
K139 of Cb helix 3; H201, N205, and H206 of the Cb helix 4-F
strand; and H166 and S167 of the Cb CC’ loop as residues crit-
ical for T cell activation and as possibly being involved in direct
CD3 interactions (residues showing more than a 50% loss in
IL-2 production). Because of the lack of many spectral changes,
only a single Cb FG loop mutant, E224A/S226A, was analyzed,
which showed a 34% decrease in IL-2 production compareds
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Figure 6. Mutations in the Helix 3 Region Indicate Loss in Specificity
of the CD3gε Interaction Site on the TCR b Subunit
(A) Plot of the scaled chemical shift difference between partially deuterated
15N-labeled 2B4b Q138A/K139A and 2B4b Q138A/K139A bound with pro-
tonated CD3gε versus the residue number of the 2B4b subunit.
(B) Plot of the ratio of NMR signal intensity between the CD3-bound state and
CD3-free state (I/I0) versus the residue number of the 2B4b subunit. The line in
the plots indicates the threshold at 1s above/below the 25% trimmed mean
deviation.
(C) Surface plot of 2B4b Q138A/K139A, with chemical shift-perturbed regions
upon titrating with CD3gε indicated in blue. The residues that show changes in
peak intensity are indicated in red. Unassigned residues are indicated in green.
Q138 and K139 are indicated in orange.
See also Figure S6.
Cellwith the wild-type. Previous studies have noted a significant loss
in T cell activity upon complete FG loop deletion (Touma et al.,
2006). Combined, this suggests that there are CD3 subunit reor-
ientations involved upon antigen presentation that result in FG
loop contact with CD3. Similarly, parts of the Cb CC’ loop
(H166 and S167) could also come into contact with both CD3
subunits upon activation, suggesting reorientation. Likewise,
NMR spectral changes in N180, K181, and F184 with CD3dε
addition and the lack of significant IL-2 reduction upon activation
might suggest CD3dε reorientation upon activation.
A TCR b Subunit Helix 3 Mutant Shows Loss in
Specificity for the CD3gε Interaction Site
To study the importance of TCR residues identified by NMR for
CD3 interaction directly, we used three 15N-labeled, partially
deuterated TCRb mutants: E133A/I134A (helix 3), Q138A/
K139A (helix 3), and Q201A/N202A (helix 4-F strand). Based on
our CSP results, we reasoned that mutations in the helix 3 and
helix 4- F strand region will affect CD3gε binding because this re-
gion had many residues that showed spectral changes upon
CD3gε titration (Figure 3A). E133A/I134A did not produce a suf-
ficient 15N-TROSY spectrum, indicating a protein bigger than
50 kDa. Light-scattering experiments revealed that it oligomer-
ized to a size of over 1,000 kDa (Figure S6A). Q138A/K139A
and Q201A/N202A produced 15N-TROSY spectra comparable
in signal quality and peak dispersion with wild-type TCRb (Fig-
ures S6B and S6C). We unambiguously assigned 82% and
65% of Q138A/K139A and Q201A/N202A, respectively, based
on the wild-type TCRbLa 15N-TROSY spectra. The change in
15N-TROSY spectra upon mutation in critical a-helical regions
is not entirely uncommon; previous instances have shown signif-
icantly altered spectra because of higher-order oligomerization,
transient interactions, or unfolding (Park et al., 2002). Light-scat-
tering experiments on Q138A/K139A indicated a molecular
weight of 60 kDa (Figure S6A). The unassigned regions include
helix 3, the helix 4-F strand, and C-terminal regions for Q201A/
N202A and the helix 3 region for Q138A/K139A. We could not
infer a lack of interaction for Q201A/N202A through CSP analysis
by adding unlabeled CD3gε because helix 3 and the helix 4-F
strand (CD3gε interacting regions) were unassigned. Q138A/
K139A did show reduced spectral changes for R204 and N205
of the helix 4-F strand region (Figure 6B), highlighting the impor-
tance of Q138 and K139 in the helix 3 region for CD3gε interac-
tion. However, some residues on the G strand near the helix 4-F
strand residues (S235 and W239) along with Q201 (helix 4-F
strand) and N161 (CC’ loop) were perturbed with CD3gε addition
(Figure 6C), losing the specificity for a contiguous region formed
by the helix 3 and helix 4-F strand regions in the wild-type TCR b
subunit (Figure 3A).
In conclusion, E133A/I134A produced 15N-TROSY spectra
evidencing a higher-order oligomer, which was confirmed with
light-scattering data (Figure S6A). 65%of Q201A/N202Awas as-
signed from the wild-type 2B4b spectra, and we were not able to
confirm lack of CD3gε interaction because the helix 3 and helix 4-
F strand regions were not assigned. However, Q138A/K139A
showed reduced intensity changes for somehelix 4- F strand res-
idues upon CD3gε addition, confirming the significance of Q138
and K139 in the Cb helix 3 region for CD3gε interaction.Reports 14, 2833–2845, March 29, 2016 ª2016 The Authors 2839
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Figure 7. The CD3gε and CD3dε Subunits Interact with the TCR on Opposite Sides
(A) A representation of the TCR-CD3gε-CD3dε complex modeled with ICM.
(B) Top view of TCR-CD3gε-CD3dε represented in (A).
(C) Schematic of the top view.
(D) Close view of TCRCb interacting with CD3gε in the dockedmodel. Q138 (helix 3) and T198 (helix 4-F strand) are predicted by themodel to H-bond with Y80 of
CD3g and Y124 of CD3ε.
(E) Close view of TCR Ca interacting with CD3dε in the docked model. N180 is H-bonded to T112, and D132 is H-bonded to S133 of CD3ε. The TCR a and b
subunits are depicted in green and cyan, respectively. CD3g, CD3d, and CD3ε are depicted light blue, dark blue, and red, respectively.Computational Docking to Generate TCR-CD3 Complex
Structure Based on NMR Analysis
To develop a 3Dmodel of the TCR-CD3 complex based on NMR
data, we used computational docking (Ferna´ndez-Recio et al.,
2003) (internal coordinate mechanics [ICM]) to generate all
possible energetically favorable conformations of CD3gε and
CD3dε structural models docked to a model of the TCR crystal
structure. The CD3gε and CD3dε subunits were each docked
to the TCR, resulting in approximately 45,000 TCR-CD3gε and
39,000 TCR-CD3dε conformations. We re-ranked these confor-
mations based on the contact surface area between the molec-
ular surfaces of CD3 subunits and the aggregate molecular
surface of the set of NMR-identified TCR residues on the TCR
structure.
CD3-TCR conformers that buried significantly more of themo-
lecular surface formedbyNMR-identified residueswere selected
and re-ranked using amolecular mechanics energy score, which
includes van der Waals, solvation electrostatics, and entropic
terms. Two CD3gε conformers exhibited a significantly better
composite contact surface area and energy score butwereminor
deviations of each other, likely representing a single strongly
predicted conformation. Two other variations of a single confor-
mation had high contact area and significantly worse but still
favorable energy scores (Table S1). These two likely represent
a single alternative conformation to the most strongly predicted
conformation. Both the primary and alternative conformations
locate the CD3gε at the same specific surface of the TCR. There-
fore, the NMR data strongly predict a single CD3gε interaction2840 Cell Reports 14, 2833–2845, March 29, 2016 ª2016 The Authorsite on the TCR, with two alternative orientations of CD3gε.
Among the CD3dε conformers, there was a single top-scoring
conformation and interaction site in terms of energy score and
contact area. The CD3gε and CD3dε orientations do not clash
with each other or with the binding sites of pMHC and CD4-
pMHC (Yin et al., 2012), even though this information was not
used to constrain the docking or theNMRexperiment. Therefore,
integration of the NMR and docking data predicts the arrange-
ment of the TCR-CD3gε-CD3dε assembly with high confidence.
The CD3gε conformers contact the Cb helix 3 and Cb helix 4-F
strand regions, with some conformers exhibiting contacts with
residues of the Ca DE loop and Cb CC’ loop. The CD3dε
conformer exhibited contacts with the Ca AB loop, Ca C strand,
Ca F strand, and Cb FG loop. A representation of the TCR-CD3
complex, using the top-scoring CD3gε conformation, is shown in
Figure 7A. The CD3dε conformer has a total contact area of
187.2 A˚2 with the NMR-identified TCR residues and energy
of 24.5 energy units (eu) (equivalent to kilocalories per mole).
The CD3gε conformer has a total contact area of 225 A˚2 with
the NMR-identified residues and energy of 23.9 eu. A movie
depicting all of the high-scoring conformers for CD3gε with
TCR-CD3dε and PDB files are provided (Movie S1; https://
nyumc.box.com/s/o5u5jiojvwdbt7myzkmuwz8no5dcoa3z). The
top view of the complex is shown in Figure 7B, which indicates
that the CD3gε and CD3dε subunits interact on opposite sides
of the TCR (Figure 7C). This contrasts the one-sided model (He
et al., 2015; Kuhns et al., 2010) but is in agreement with TCR-
CD3dε SAXS data (Birnbaum et al., 2014).s
By analyzing the individual residue contributions to the overall
contact area in a particular conformation, we found that Q138
(Cb helix 3), T198, and R204 (both Cb helix 4-F strand) had sig-
nificant contacts (>10%contribution) with CD3gε in at least three
of the four different predicted conformations. Notably, Q138A/
K139A, E133A/I134A (nearer to Q138), and H201A/N202A
(nearer to T198) produced significantly less IL-2, suggesting
that these residues are important to T cell signaling. In ourmodel,
Q138 and T198 contact Y80 (in CD3g) and Y124 (in CD3ε),
respectively (Figure 7D). Similarly, in the CD3dε conformer,
D132 in the Ca AB loop and N180 in the Ca F strand, make sig-
nificant contributions to the overall contact area. D132 contacts
S133 and N180 contacts T112 of CD3ε in the conformer
(Figure 7E).
In summary, top-scoring conformations from docking CD3 to
TCR were ranked by high total contact area between the NMR-
perturbed amino acids and the docked CD3 conformations and
molecular energetics, revealing a strongly preferred extracel-
lular TCR-CD3 assembly. In the absence of a large amount of
induced fit upon CD3-TCR association, which cannot be as-
sessed by the method we used, these data clearly suggest
that CD3gε associates with an interaction surface that contains
the Cb helix 3 and helix 4-F strand regions and that CD3dε as-
sociates with the Ca F strand and C strand regions. This yields
a two-sided model for the TCR-CD3 interaction wherein CD3gε
and CD3dε interact at opposing sides of the TCR (Figures 7A
and 7B). The Cb FG loop did not provide significant contacts
with CD3gε in our docking studies, although the CD3dε confor-
mation showed interactions with the FG loop. The Ca AB loop,
which undergoes conformational change upon agonist ligation
(Beddoe et al., 2009), interacts with CD3dε in our model. The
Cb CC’ loop did not produce sufficient spectral changes in
our NMR experiments and, therefore, was not used as a guide
in our docking analysis.
DISCUSSION
In this study, NMR spectroscopy, T cell hybridoma functional as-
says, and computational docking were used to visualize the
TCR-CD3 complex. The size and spectral complexity problems
of a full-length TCR were overcome by using perdeuteration
and partial subunit labeling. Although single-chain TCR has
been used previously to look at CDR mobility (Varani et al.,
2007), this study is the first in which NMRbackbone assignments
have been obtained on both subunits of a full-length TCR.
Although one limitation is that the perturbations identified by
NMR may represent an aggregate imprint of a dynamic
ensemble of CD3-TCR interactions, the consistency between
docking and experimental observations converging on one inter-
action site each for CD3gε and CD3dε with the TCR argues
against this scenario. This is further supported by the comple-
mentarity, rather than clash, of the independently docked
CD3gε and CD3dε sites on opposing sides of the TCR.
The important question of how the TCR is triggered has been
obscured by the lack of atomic detail structural information. Un-
derstanding how TCR-ligand engagement results in phosphory-
lation of the CD3 cytoplasmic tail requires knowledge of how the
TCR, which lacks signaling capacity, transmits the informationCellreceived via its variable region through interaction of its constant
region with the CD3 ectodomain.
We determined that CD3gε interacts with residues of the helix
3 and helix 4-F strand regions on the TCR b subunit, with some
conformers in contact with the Ca DE loop and Cb CC’ loop as
well (Kuhns and Davis, 2007), and that CD3dε interacts with res-
idues of the F and C strands on the TCR a subunit (Figure 7A).
Previous work has identified several Cb helix 4-F strand mutants
(F199, N202, and R204) showing reduced TCR surface expres-
sion; however, T cell activation was not assessed with those mu-
tants (Fernandes et al., 2012). Recently, NMR chemical shift
perturbation analysis (He et al., 2015) identified Cb helix 3 and
helix 4 residues as the binding site for both CD3 subunits, which
is incompatible with the two-sided model. We have shown,
through reciprocal chemical shift analysis, that CD3gε and
CD3dε can bind the TCR individually without the requirement
of the other CD3 subunit (Figure 4), arguing against the one-
sided model (He et al., 2015). That each CD3 subunit can bind
independently was recently quantified with 2D binding analysis
(Huang et al., 2010) using immobilized TCR and CD3 extracel-
lular subunits (C. Ge, A.N., M.K., and C. Zhu, unpublished data).
Identification of specific interacting residues may provide in-
sights into the nature of the TCR and CD3 interaction. Notably,
contacts between TCR and CD3 were observed that are consis-
tent with hydrogen bonds. These CD3-interacting regions are on
opposite sides of the TCR, as predicted previously (Sun et al.,
2004) in the resting condition, contradicting the one-sidedmodel
(He et al., 2015; Kuhns et al., 2010). However, this two-sided
model cannot rule out CD3 subunit reorientations upon antigen
ligation to expose intracellular ITAMs for phosphorylation. The
TCR-CD3dε SAXS and pMHC-TCR-CD3 electron microscopy
(EM) structure also points to the two-sided model (Birnbaum
et al., 2014). Our model bears similarity to the proposed
CD8-CD3d-a-connecting peptide motif interactions needed for
proper pMHC binding (Werlen et al., 2003). The current NMR-
derived structure is physiologically relevant to the resting state
interactions between TCR-CD3gε and TCR-CD3dε. This may
be crucial for understanding the conformational changes or sub-
unit movement that may occur upon antigen ligation.
Birnbaum et al. (2014) have suggested that CD3gε and CD3dε
interact ‘‘below’’ TCRb and TCRa, respectively, near the plasma
membrane, but residue-specific detail is unattainable in EM
studies because of low resolution. Our work predicts that the
CD3dε subunit interacts adjacent to (on the ‘‘side’’ of) the con-
stant domain of the TCR a subunit rather than below it. Confor-
mational changes in the TCR have been implicated in playing a
role in differential T cell activation (varying activation potential
for different antigenic peptides) (Krogsgaard et al., 2003). This in-
volves residues in different regions of the TCR interacting with
the CD3 subunits based on the type/strength of antigen. There-
fore, it is important to know the CD3-interacting residues on the
TCR under resting conditions.
The Ca regions, namely the F strand, C strand, and AB loop,
implicated in TCR dimerization (Kuhns et al., 2010) are
involved in CD3dε binding based on our data. One possible
explanation could be that antigen ligation induces a torque
or conformational change on the TCR (Krogsgaard et al.,
2003) that frees these regions and exposes them forReports 14, 2833–2845, March 29, 2016 ª2016 The Authors 2841
dimerization, leading to TCR clustering. More recently, me-
chanical forces (Das et al., 2015; Kim et al., 2009; Liu et al.,
2014; Ma and Finkel, 2010; Pryshchep et al., 2014) have
been shown to induce such changes and trigger T cell activa-
tion. Conformational changes upon antigen ligation could
possibly lead to CD3gε interacting with the Cb FG loop, stabi-
lizing the FG loop and influencing the TCR-pMHC bond lifetime
(Das et al., 2015). The permissive geometry (Adams et al.,
2011) and lipid-based (Shi et al., 2013) models, wherein the
CD3 ITAMs are resistant to phosphorylation in the resting con-
dition, still hold in this two-sided model. The two-sided binding
model does not necessarily rule out pre-clustering of the TCR
on the T cell membrane (Alarco´n et al., 2006; Lillemeier et al.,
2010; Roh et al., 2015) and has implications for TCR clustering,
seen as a mechanism for signal amplification upon antigen
binding. According to the model, clustering might occur
through the interactions between CD3 subunits of neighboring
TCR-CD3 complexes or might require CD3 subunit rearrange-
ment upon antigen binding to promote TCR-TCR interaction.
Hypothetically, CD3 subunit rearrangement could bring the
intracellular CD3 ITAMs into close vicinity with each other,
thereby promoting trans-autophosphorylation (Kuhns et al.,
2010). A similar conformational change at the CD3zz juxta-
membrane region has been shown recently (Lee et al., 2015).
Moreover, the pMHC-TCR-CD3 EM structure has suggested
TCR-CD3 subunit rearrangement upon antigen ligation (Birn-
baum et al., 2014) for signal propagation.
Our results examine a long-standing question regarding the
orientation of CD3 subunits in the TCR-CD3 complex during
resting conditions. The study suggests an answer to one of
the fundamental questions in immunology and receptor recog-
nition: how ligand engagement of TCR mediates critical infor-
mation transfer from the antigen recognition site in the external
environment to the intracellular compartment via the CD3
signaling complex. This may also allow us to understand other
receptor-mediated cell activation systems. An understanding of
the molecular organization of the TCR-CD3 signaling complex
has wide significance for manipulating immune functions to
cancer, viral infections, inflammation and autoimmunity,
including antibodies (Martin et al., 2013), modified T cells
(Rosenberg and Restifo, 2015), and small molecules that either
dampen or enhance T cell signaling. This work also illustrates
the capabilities of NMR spectroscopy in the study of other im-
mune and protein complexes. Our subunit-specific labeling
scheme could be used to study a variety of large multimeric
proteins such as gdTCR, NKT TCR, B cell receptors, various
immunoglobulin (Ig) molecules, reverse transcriptases, and
kinesins.EXPERIMENTAL PROCEDURES
Triple-Resonance Experiments for Backbone Assignments
Soluble full-length 2B4 TCR (containing constant domains from human LC13
TCR) was generated by E. coli inclusion body expression, protein refolding,
and purification as described previously (Newell et al., 2011). Only one of the
subunits (either a or b) is isotopically labeled (2H/13C/15N) and linked through
disulfide linkage to the other deuterated (2H/12C/14N) subunit (either b or a).
The labeled a linked to unlabeled b is hereafter referred to as the 2B4aLb sam-
ple, and the labeled b linked to unlabeled a is hereafter referred to as the2842 Cell Reports 14, 2833–2845, March 29, 2016 ª2016 The Author2B4bLa sample. Perdeuterated (>95% deuteration) subunits were made by
culturing BL21(DE3) E. coli cells expressing 2B4 subunits stepwise in medium
containing increasing proportions of D2O (25%, 50%, and 75%) and finally into
100% D2O medium containing
15NH4Cl +
13C-2H-glucose or 14NH4Cl +
12C-2H-glucose (Gardner and Kay, 1998). The refolded protein was concen-
trated and purified by anion exchange chromatography (diethylaminoethyl
[DEAE] column) and gel filtration (S200) (Figure S1D). The protein was
exchanged to buffer containing 200 mM 2-(N-morpholino)ethanesulfonic
acid (MES) and 100 mM arginine (pH 7.0) for NMR experiments.
TROSY-based triple-resonance experiments (Salzmann et al., 1998) were
performed on the perdeuterated 300 mM sample of 2B4bLa at 37C on 600
and 800MHz spectrometers to obtain the backbone N, HN, Ca, and C’ assign-
ments. The data were processed by NMRPipe (Delaglio et al., 1995) and
analyzed by NMRView (Johnson, 2004). About 75% of the assignable back-
bone N and HN were assigned. 65% of these assignments were transferred
to the 22C 15N-TROSY spectra without ambiguity (80% of the constant
domain was assigned) (Figure S2B). This transfer was needed because the
CD3 subunits were not stable at 37C. Similar NMR experiments on a perdeu-
terated 200 mM sample of 2B4aLb on a 600 MHz spectrometer yielded about
60% of the assignable backbone N and HN assignments (60% of the constant
domain were assigned) (Figure S2A). 15N-TROSY spectra of 2B4aLb at
concentrations higher than 200 mM indicated aggregation that involved the a
subunit. This restricted us from using higher concentrations of 2B4aLb to get
better-quality triple-resonance experimental data. The accession number for
the 2B4 TCR NMR assignments reported in this paper is BMRB: 26751.
Expression and Purification of CD3 Subunits for NMR
To study the 2B4 TCR interaction with CD3 subunits by NMR, the constructs
for ectodomain human CD3gε and CD3dε subunits (Kjer-Nielsen et al., 2003,
2004), wherein the two subunits are linked by a 26-residue linker, were used.
E. coli BL21(DE3) expressing CD3 proteins was grown at 37C in Luria-Bertani
(LB) medium and transferred into 250 ml minimal medium containing
12C-glucose, 14NH4Cl, and 75% D2O (Marley et al., 2001) before induction
and cultured. CD3 inclusion bodies were refolded and purified in a manner
described previously (Kjer-Nielsen et al., 2004; Figures S1B–S1F). After purifi-
cation, the CD3 protein samples were exchanged, using an Amicon concen-
trator, to the same NMR buffer used for the TCR sample.
CD3 Subunit Titration with Labeled 2B4 for Chemical Shift
Perturbation Analysis
Unlabeled deuteratedCD3gε titrations with perdeuterated 15N-labeled 2B4bLa
were done at 22C on an 800 MHz spectrometer equipped with a 1.7 mm
cryoprobe. 15N-TROSY was collected on samples with 2B4bLa:CD3gε con-
centration ratios of 100:0, 100:200, 100:500, and 100:900 mM, each adjusted
to a final volume of 30 ml (Figures 1B–1D). All other CSP experiments were
performed at 22C on spectrometers equipped with a 5 mm cryoprobe. Unla-
beled deuterated CD3gε titrations with perdeuterated 15N-labeled 2B4aLb
were done on a 600MHz spectrometer. 15N-TROSYwas collected on samples
with the following 2B4aLb:CD3gε concentrations ratios: 38:0 mM (1:0),
35.4:35.4 mM (1:1), 33:66 mM (1:2), and 29:116.5 mM (1:4) (Figure S3A). Unla-
beled deuterated CD3dε titrations with perdeuterated 15N-labeled 2B4bLa
were done on a 500MHz spectrometer.15N-TROSY was collected on samples
with the following 2B4bLa:CD3dε concentration ratios: 58.5:0 mM (1:0),
46.7:93.4 mM (1:2), 42.4:127.3 mM (1:3), and 38.9:155.5 mM (1:4) (Figure S3D).
Unlabeled deuterated CD3dε titrations with perdeuterated 15N-labeled 2B4aLb
were done on a 600MHz spectrometer. 15N-TROSYwas collected on samples
with the following 2B4aLb:CD3dε concentration ratios: 37:0 mM (1:0),
33.5:33.5 mM (1:1), 30.6:61.2 mM (1:2), and 25:112.6 mM (1:4.5) (Figure S3H).
Unlabeled CD3dε was added to perdeuterated 15N-labeled 2B4aLb to achieve
a 2B4aLb:CD3dε concentration ratio of 80:290 mM (1:3.6) for the higher-con-
centration CSP experiment. In each titration case, assignments were carefully
transferred from the CD3-free TROSY spectra to saturated TROSY spectra.
The scaled chemical shift was calculated based on the equation dppm =
((D1H)2+0.11(D15N)2)0.5 (Natarajan et al., 2012), where D1H and D15N denote
the chemical shift difference for a given residue between the CD3-free state
and CD3-bound state. The residues that showed spectral changes were iden-
tified when they showed scaled chemical shift changes greater than 1s aboves
the 25% trimmed mean deviation when comparing them in the presence and
absence of saturated amounts of the CD3 and when they showed less than 1s
below the 25% trimmedmean deviation in the ratio of NMR signal intensity be-
tween the CD3-saturated state and CD3-free state (Figure 2).
2B4 Titration with Labeled CD3 Subunits for Chemical Shift
Perturbation Experiments
Deuterated 15N-labeled CD3gεwas produced using LBmedium prior to induc-
tion and 15NH4Cl in M9 minimal D2O medium after induction. Protonated
15N-labeled CD3dε was produced using 15NH4Cl in M9 minimal medium. Un-
labeled protonated 2B4 TCRs were produced using LB medium. Unlabeled
2B4 titrations with deuterated 15N-labeled CD3gε in NMR buffer were done
on a 600 MHz spectrometer equipped with a 5 mm cryoprobe at 22C.
15N-TROSY was collected at each titration point with 256 incremental points
in the indirect dimension with 128 scans. 15N-TROSY was collected on sam-
ples with the following CD3gε:2B4 concentrations: 40:0 mM (1:0), 35:71 mM
(1:2), and 34:93 mM (1:2.7) (Figure 4A). Unlabeled 2B4 titrations with
15N-labeled CD3dε in PBS were done on a 600 MHz spectrometer equipped
with a 5 mm cryoprobe at 22C. 15N-TROSY was collected on samples with
the following CD3dε:2B4 concentration ratios: 120:0 mM (1:0), 110:165 mM
(1:1.5), and 105.5:263.8 mM (1:2.5) (Figure 4B).
Mutant T Cell Hybridoma Analysis for IL-2 Production
Mouse 58/ T cell hybridoma cells (Letourneur and Malissen, 1989), which
expresses mouse CD3 but not TCRab, (from David Kranz, University of Illinois)
and CHO cells expressing I-Ek (Krogsgaard et al., 2005) (from Mark M. Davis,
Stanford University) were cultured in RPMI 1640 medium and DMEM respec-
tively, supplemented with 10% FBS, sodium pyruvate, non-essential amino
acids, glutaMAX-1, and penicillin-streptomycin. The mutant mouse 2B4 TCR
constructs were generated by PCR using overlapping primers containing the
mutant sequences and cloned into the retroviral pMX vector (Kitamura et al.,
2003). Retroviral transductions of the hybridoma cells were done as described
previously (Malecek et al., 2013, 2014; Zhong et al., 2010, 2013). The trans-
duced cells were stained with phycoerythrin (PE) anti-CD3ε and allophycocya-
nin (APC) anti-TCRb (clone H57-597) antibodies. The cells were then sorted
using a Sony SY3200 sorter. The sorted cells were expanded for 6 days, quan-
tified for TCR expression (Figures S5G–S5J), and prepared for the cytokine
assay. 105 CHO-IEk cells were loaded with different concentrations of K5 pep-
tide and incubated with 105 T cell hybridoma clones for 16 hr at 37C, 5%CO2.
A standard ELISA sandwich was used to quantify cytokine IL-2 production
(Malecek et al., 2013; Figures S5A–S5F). The area under the curve for wild-
type and mutant IL-2 production was calculated after non-linear fitting using
Prism (GraphPad software).
CD3gε Subunit Titration with Labeled 2B4bMutants for Chemical
Shift Perturbation Analysis
The mutant 2B4b TCR (E133A/I134A, Q138A/K139A, and Q201A/N202A)
construct was generated using the QuikChangemutagenesis kit (Agilent Tech-
nologies) using overlapping primers containing the mutant sequences. E. coli
BL21(DE3) expressing 2B4 proteins (a wild-type, b mutants) was grown at
37C in LB medium and transferred into 250 ml minimal medium containing
15NH4Cl (
14NH4Cl for the a subunit) and 75% D2O (Marley et al., 2001) before
induction. Unlabeled CD3gε was expressed in LB medium. The proteins were
refolded and purified as described above. Unlabeled protonated CD3gε addi-
tions with partially deuterated 15N-labeled 2B4bLamutants in NMRbuffer were
done on a 600 MHz spectrometer equipped with a 5 mm cryoprobe at 22C.
The experiments were collected before and after CD3gε addition with 256
incremental points in the indirect dimension. 15N-TROSY was collected on
samples with the following 2B4:CD3gε concentration ratios: Q201A/N202A,
60:0 mM (1:0) and 50:200 mM (1:4); Q138A/K139A, 40:0 mM (1:0) and
30:120 mM (1:4) (Figures S6B and S6C). Multi-angle light scattering (MALS)
experiments on the 2B4 wild-type and mutants were performed on a Wyatt
miniDAWN TREOS detector.
ICM Docking for the TCR-CD3 complex
All docking, energy calculations, and contact area calculations were done with
ICM (Molsoft, Inc.). A molecular model of the 2B4 TCR ab dimer was madeCellbased on the crystal structure 3QJF (PDB ID). A molecular model of CD3εg
was made with PDB ID 1SY6, and that of CD3dε was made with PDB ID
1XIW. The ICM protein-protein docking algorithm was used as described pre-
viously (Ferna´ndez-Recio et al., 2003) to dock the TCR to CD3εg and CD3dε.
The contact surface area between each docked conformation of
CD3εg or CD3dε, respectively, and the TCR was calculated with the
calcResContactArea macro in ICM. For TCR-CD3εg, the contact area contrib-
uted by the following NMR-derived residues of the TCR b chain was summed:
V11, A18, E41, Q55, Q56, F64, S65, I78, S86, C91, A92, S93, E133, I134, Q138,
K139, T141, D152, S157, V169, Q179, S190, S196, F199, W200, R204, N205,
F213, S217, T223, and Q232. Similarly, for each TCR-CDdε conformation, the
contact area contributed by the following NMR-derived residues of the TCR a
chain was summed: Q5, S11, T19, S21, C25, Q38, R42, L48, L51, K68, A91,
N99, G104, T107, S134, Q149, S150, M165, N180, K181, F184, D198, T199,
and E205. The residue numbers are all based on the NMR constructs used
in this study.
The distribution of contact surface areas of the docked conformations was
observed to be a Boltzmann distribution and was modeled as such. Outliers
with significantly higher contact surface areas between CD3εg or CD3dε,
respectively, and the TCR were kept and re-ranked by energy score. Confor-
mations with similar energy scores and a root-mean-square deviation
(RMSD) < 0.001 A˚2 were quantitatively considered a single conformation.
Conformations targeting the same specific interaction site on the TCR may
be qualitatively considered to be equivalent even if they exhibit different
rotational orientations, given the margin of error of the procedure (e.g., static
structure in a crystal lattice used for docking, dynamic NMR measurements
in solution).
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